Clinical Trial Update: Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tacrolimus-based immunosuppression with steroids versus a monoclonal anti-IL2R antibody in hepatitis C–positive liver transplant patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Transplantation

Drugs mentioned

• Basiliximab (basiliximab)
• Corticosteroids (corticosteroids)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Hepatitis C, Liver Transplantation | Phase 2 | Status: COMPLETED